Saturday, April 30, 2022
"alarm findings" of preeclampsia
Friday, April 29, 2022
cephalosporins in renal insufficiency
Thursday, April 28, 2022
6 Ps of acute limb ischemia
- pain
- pallor
- poikilothermia
- pulselessness
- paresthesia
- paralysis
Wednesday, April 27, 2022
IV steroid in toxic megacolon due to IBD
Tuesday, April 26, 2022
sweating - a side-effect of drugs
Monday, April 25, 2022
Propofol and pupillary diameter
Sunday, April 24, 2022
Bovis and colonic CA
Saturday, April 23, 2022
Small bowel vs colon as source of diarrhea
Friday, April 22, 2022
Provocative angiography
Thursday, April 21, 2022
Linezolid induced LA
Wednesday, April 20, 2022
Median time intervals of different anaphylaxes
- iatrogenic anaphylaxis - 5 minutes
- stinging insect venom-induced anaphylaxis - 15 minutes
- food-induced anaphylaxis - 30 minutes
Tuesday, April 19, 2022
Platypnea-orthodeoxia syndrome
Monday, April 18, 2022
Timing of Type B AD
- Hyperacute: <24 hours
- Acute: 1 to 14 days
- Subacute: 15 to 90 days
- Chronic: >90 days
Sunday, April 17, 2022
Leriche syndrome
- claudication
- absent or diminished femoral pulses
- erectile dysfunction
Saturday, April 16, 2022
TTBI
- Yersinia enterocolitica
- Pseudomonas fluorescens
- Enterobacter
- Serratia
Friday, April 15, 2022
Spasticity and Rigidity
Thursday, April 14, 2022
Myxedema
- mental status change, and
- hypothermia (may mask signs of infection)
Wednesday, April 13, 2022
PPH - predictor
Tuesday, April 12, 2022
bag-mask ventilation in an edentulous patient
Monday, April 11, 2022
Coffee Bean sign
Sunday, April 10, 2022
MESA score
Friday, April 8, 2022
IV to PO morphine
Q: What is an estimated IV to PO conversion ratio of Morphine?
Answer: 1:3
While converting intravenous (IV) to oral (PO) opioids two principles should be kept in mind
- Conservative estimates should be used.
- The optimal dose should be found with judicious titration due to the fact that cross-tolerance equivalency is not established.
Thursday, April 7, 2022
CBC reading
Wednesday, April 6, 2022
Dialysis in TLS
Q: Which of the following is NOT an indication for early dialysis in patients with Tumor Lysis Syndrome (TLS)? (select one)
A) hyperkalemia
B) Hyperphosphatemia
C) hypercalcemia
D) High uric acid
Answer: C
The objective of this question is to highlight the low threshold of initiating dialysis in patients who develop TLS. This low threshold is due to two reasons:
1. Hyperkalemia occurs relatively fast in TLS due to rapid potassium release and can be fatal with superimposed oliguria.
2. Rapid reduction of uric acid and phosphate levels is vital in preventing End-Stage Renal Disease (ESRD).
Usually, symptomatic hypocalcemia (not hypercalcemia) is a norm in TLS. This is due to hyperphosphatemia (choice C).
#nephrology
#oncology
References:
1. Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 2004; 127:3.
2. Tan HK, Bellomo R, M'Pis DA, Ronco C. Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration. Int J Artif Organs 2001; 24:186.
Tuesday, April 5, 2022
Osborn wave
Monday, April 4, 2022
Causes of WE
- inadequate dietary intake
- decreased gastrointestinal (GI) absorption,
- reduced liver storage, and
- impaired utilization
- Anorexia nervosa
- Poor diet
- Hyperemesis gravidarum
- GI pathology
- Bariatric surgery
- Malignancy
- Transplant
- Hemo or peritoneal dialysis
- AIDS
- Genetic disorder of thiamine metabolism
Sunday, April 3, 2022
Cholestyramine in thyroid storm
Saturday, April 2, 2022
COVID, cancer and DVT
Q: Cancer patients who develop COVID-19 infection are more prone to develop thrombosis than non-cancer patients? (select one)
A) True
B) False
Answer: B
Although in general cancer patients are more at risk for developing Deep Venous Thromboses (DVTs) but fortunately, COVID-19 infection doesn't increase that risk, despite the hypercoagulability tendency of COVID-19. This applies to both arterial and venous thromboses.Friday, April 1, 2022
ARB and enteropathy
Q: 58 years old male with history of hypertension but stable on a single medicine for the last two years is admitted to ICU with worsening diarrhea, hypovolemia, and impending kidney failure. Which of the following anti-hypertensive is more prone to produce "sprue-like enteropathy"? (select one)
A) Irbesartan (Avapro)
B) Losartan (Cozaar)
C) Olmesartan (Benicar)
D) Valsartan (Diovan)
E) Candesartan (Atacand)
Answer: C
One of the popular angiotensin II receptor blockers (ARBs) olmesartan is associated with "sprue-like enteropathy". Although intestinal biopsy shows villous atrophy, though antibody testing for celiac disease stays negative. Diagnosis is based on rechallenging the drug, clinical symptoms, and intestinal biopsy. ACE inhibitors or other ARBs have not been implicated yet.